Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

被引:3
|
作者
Van Deutekom, Colinda [1 ]
Geelhoed, Bastiaan [1 ]
Van Munster, Barbara C. [2 ]
Bakker, Stephan J. L. [3 ]
Gansevoort, Ron T. [3 ]
Van Gelder, Isabelle C. [1 ]
Rienstra, Michiel [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
来源
OPEN HEART | 2023年 / 10卷 / 02期
基金
欧盟地平线“2020”;
关键词
Atrial Fibrillation; EPIDEMIOLOGY; RISK FACTORS; HEART-FAILURE; POPULATION; MORTALITY; OUTCOMES;
D O I
10.1136/openhrt-2023-002315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveAtrial fibrillation (AF) is a condition that occurs in the presence of comorbidities. With the accumulation of comorbidities (multimorbidity), some combinations may more often occur together than others. Information on the impact of clustering of these on incident AF is sparse. We aimed to investigate clustering of cardiovascular and renal comorbidities and study the association between comorbidity clusters and incident AF. MethodsWe used the community-based Prevention of Renal and Vascular ENd-stage Disease (PREVEND) cohort in which 8592 individuals participated. Latent class analysis was performed to assess clustering of 10 cardiovascular and renal comorbidities. ResultsWe excluded individuals with prior AF or missing ECG data, leaving 8265 individuals for analysis (mean age 48.9 & PLUSMN;12.6 years, 50.2% women). During 9.2 & PLUSMN;2.1 years of follow-up, 251 individuals (3.0%) developed AF. A model with three clusters was the optimal model, with one cluster being young (44.5 & PLUSMN;10.8 years) and healthy, carrying a low (1.0%) risk of incident AF; one cluster being older (63.0 & PLUSMN;8.4 years) and multimorbid, carrying a high (16.2%) risk of incident AF and a third middle-aged (57.0 & PLUSMN;11.3 years), obese and hypertensive cluster carrying an intermediate risk (5.9%) of incident AF. While the prevalence of the comorbidities differed between classes, no clear combination(s) of comorbidities was observed within the classes. ConclusionsWe identified three clusters of comorbidities in individuals in the community-based PREVEND cohort. The three clusters contained different amount of comorbidities carrying different risks of incident AF. However, there were no differences between the clusters regarding specific combination(s) of comorbidities.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Atrial Fibrillation and Risk of Dementia: A Prospective Cohort Study
    Dublin, Sascha
    Anderson, Melissa L.
    Haneuse, Sebastien J.
    Heckbert, Susan R.
    Crane, Paul K.
    Breitner, John C. S.
    McCormick, Wayne
    Bowen, James D.
    Teri, Linda
    McCurry, Susan M.
    Larson, Eric B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (08) : 1369 - 1375
  • [42] Multimorbidity In Patients With Atrial Fibrillation: A Community Study
    Chamberlain, Alanna M.
    Alonso, Alvaro
    Noseworthy, Peter A.
    Killian, Jill
    Weston, Susan
    Roger, Veronique L.
    Ryu, Euijung
    CIRCULATION, 2021, 143
  • [43] Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation
    Shaikh, Fahad
    Pasch, Lachlan B.
    Newton, Phillip J.
    Bajorek, Beata V.
    Ferguson, Caleb
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (05)
  • [44] Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation
    Fahad Shaikh
    Lachlan B. Pasch
    Phillip J. Newton
    Beata V. Bajorek
    Caleb Ferguson
    Current Cardiology Reports, 2018, 20
  • [45] Atrial fibrillation and risk of stroke: a nationwide cohort study
    Christiansen, Christine Benn
    Gerds, Thomas A.
    Olesen, Jonas Bjerring
    Kristensen, Soren Lund
    Lamberts, Morten
    Lip, Gregory Y. H.
    Gislason, Gunnar H.
    Kober, Lars
    Torp-Pedersen, Christian
    EUROPACE, 2016, 18 (11): : 1689 - 1697
  • [46] DRUG MAY INCREASE CARDIOVASCULAR EVENTS IN THOSE WITH PERMANENT ATRIAL FIBRILLATION
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2011, 111 (12) : 24 - 24
  • [47] Cardiovascular risk progression into atrial fibrillation tracked with wearables: a report from mAFA II extension cohort
    Guo, Y.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [48] Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation
    Claxton, J'Neka S.
    Chamberlain, Alanna M.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Bengtson, Lindsay G. S.
    Alonso, Alvaro
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (10): : E554 - E567
  • [49] Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: A nationwide population-based cohort study
    Hung, Chen-Ying
    Lin, Ching-Heng
    Wang, Kuo-Yang
    Huang, Jin-Long
    Hsieh, Yu-Cheng
    Loh, El-Wui
    Lan, Tsuo-Hung
    Chou, Pesus
    Ting, Chih-Tai
    Wu, Tsu-Juey
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1131 - 1136
  • [50] Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
    Byambasukh, Oyuntugs
    Eisenga, Michele F.
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    Corpeleijn, Eva
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (09) : 905 - 916